focus -WSS

focus

author：knowledge 2025-08-04 03:41:49 - browse：3

UnitedHealth Group appears to be offering some providers more substantial loans in the wake of the cyberattack on Change Healthcare, according to three doctors who each saw their advances increase up to seven figures.

The apparent change comes as hospitals, doctors, and lobbying groups have for weeks complained about low offers from the company, in some cases less than 1% of their typical weekly billing. Initially, after a mid-February cyberattack took its system offline, hampering insurers’ ability to receive claims and send payments, UnitedHealth offered loans to bridge the gap while the company worked to fix the outage, but many providers said it didn’t accomplish that.

It’s not clear exactly what prompted the change in these providers’ offers, or how broadly it applies. The new offers came just days after UnitedHealth officials met virtually with Health and Human Services Secretary Xavier Becerra and other White House officials. At that meeting, HHS said it explicitly asked UnitedHealth to send advance payments to providers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Sanofi strikes deal with Novavax, boosting the vaccine maker

WSS

After decades in use, heart stents finally beat placebo

A letter from the executive editor: STAT UnitedHealth investigation

White House drug czar issues call for 'recovery

Study: Adult vaccinations pay for themselves in societal benefits

Researchers on aging grapple with how to calculate biological age

What nurses really want: sufficient staffing for patient care

knowledge

focus

Wikipedia

How one medical school became remarkably diverse

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Supreme Court strikes down use of affirmative action

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Heart attack and stroke risk calculators need revising

Shionogi licenses Pompe disease therapy from Maze Therapeutics

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Making AI in medicine accessible to smaller, and rural hospitals

knowledge

Ventyx halts psoriasis drug development after lackluster trial results

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Study: Adult vaccinations pay for themselves in societal benefits

Steward Health Care files for bankruptcy

NIH chief: government has fallen behind pharma on clinical trials

FDA reorg will put new emphasis on investigations, sources say

hotspot

focus

leisure time

knowledge